In these cancers, the methylation of the promoter regions of tumor suppressor genes, such as CDH1, APC, MGMT, RASSF1A, GSTP1, p16 and RAR-β2, affect the activity of tumor suppressor genes, typically leading to transcriptional silencing. The gene discussed is CDH1; the disease is neoplasm.